In this study, we demonstrated that plasmid encoding mouse IL-12 (pIL-12) delivered by GET directly into the tumor was able to recruit and/or induce the proliferation of immune cells, which led to efficient tumor suppression (Figure 1B–D). This evidence concerns the gene SPRR2A and neoplasm.